Rebecca Rubin Senior Film and Media Reporter The Jack Quaid-led action comedy “Novocaine” will vie with last weekend’s champion “Mickey 17” for the top spot on box office charts.
Based on projections, “Novocaine” should lead the way with $10 million to $12 million from 3,300 North American theaters in its first weekend of release.
The film, from Paramount Pictures, cost $18 million. In “Novocaine,” Quaid plays an introverted everyman with the inability to feel pain, which he uses to his advantage after his dream girl is taken hostage in a bank robbery.
Those ticket sales should be enough to topple “Mickey 17,” which is expected to decline by 55% to 60% from its $19 million debut, putting second-weekend revenues around $8 million to $9 million.
Read more on variety.com